Scarinci, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 834
EU - Europa 773
AS - Asia 264
SA - Sud America 6
Totale 1.877
Nazione #
US - Stati Uniti d'America 826
DE - Germania 241
SE - Svezia 160
IT - Italia 106
SG - Singapore 96
CN - Cina 89
UA - Ucraina 55
FR - Francia 47
IE - Irlanda 47
FI - Finlandia 40
IN - India 27
ID - Indonesia 25
GB - Regno Unito 24
RU - Federazione Russa 14
BE - Belgio 12
PL - Polonia 12
TR - Turchia 12
CA - Canada 7
IR - Iran 6
AR - Argentina 3
BR - Brasile 3
HK - Hong Kong 3
NL - Olanda 3
RO - Romania 3
ES - Italia 2
HU - Ungheria 2
MY - Malesia 2
PH - Filippine 2
AT - Austria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
IQ - Iraq 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
Totale 1.877
Città #
Chandler 222
Singapore 80
Ashburn 75
New York 51
Dublin 45
San Mateo 43
Jacksonville 41
Helsinki 27
Jakarta 25
Marseille 20
Wilmington 20
Milan 19
Ann Arbor 18
Dearborn 18
Bremen 16
Houston 14
Nanjing 14
Nürnberg 13
Izmir 12
Kraków 12
Lawrence 12
Princeton 12
Rome 12
Boston 11
Brussels 11
Munich 11
Cattolica 9
Fairfield 8
University Park 8
Beijing 7
Leawood 7
Los Angeles 7
Nanchang 7
Redmond 7
Woodbridge 7
Redwood City 6
Seattle 6
Augusta 5
Hebei 5
Lancaster 5
Mountain View 5
Cambridge 4
Frankfurt am Main 4
London 4
Moscow 4
Shenyang 4
Tianjin 4
Toronto 4
Bregano 3
Changsha 3
Falkenstein 3
Hangzhou 3
Hong Kong 3
Jiaxing 3
Ottawa 3
Paris 3
Pescara 3
Sacramento 3
Shanghai 3
Vienna 3
Angeles City 2
Ardabil 2
Boardman 2
Bologna 2
Budapest 2
Fremont 2
Guangzhou 2
Harbin 2
Hefei 2
Indiana 2
Kuala Lumpur 2
Norwalk 2
Pune 2
Riverside 2
Santiago De Compostela 2
Simi Valley 2
Vietri Sul Mare 2
Vigodarzere 2
Washington 2
Zhengzhou 2
Amsterdam 1
Andover 1
Aradeo 1
Baghdad 1
Bern 1
Brno 1
Buenos Aires 1
Chengdu 1
Chicago 1
Chiswick 1
Civitavecchia 1
Costa Mesa 1
Dalian 1
Delhi 1
Edinburgh 1
Essen 1
Florence 1
Forest City 1
Frascati 1
Fuzhou 1
Totale 1.077
Nome #
Assessment of insulin resistance in lean women with polycystic ovary syndrome. 149
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT 148
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 110
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 90
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial 87
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 84
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 81
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 78
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 77
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action 77
The Performance of Serum Antimullerian Hormone and Antral Follicle Count in Predicting the Ovarian Response in Intrauterine Insemination 76
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 75
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study 73
Circulating irisin levels in functional hypothalamic amenorrhea: a new bone damage index? A pilot study. 73
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function 70
Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk 66
Hysterosalpingo-contrast-sonography (HyCoSy) in the assessment of tubal patency in endometriosis patients 63
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: A RCT 58
"Hormone of darkness" and human reproductive process: direct regulatory role of melatonin in human corpus luteum 58
Alpha-Lipoic Acid May Improve the Clinical, Endocrine and Metabolic Features of Polycystic Ovary Syndrome through an Insulin-Sensitizing Effect and an Antioxidant Action 58
Psoriasis and polycystic ovary syndrome: A new link in different phenotypes 55
Thyroid Stimulating Hormone (TSH) and Human Corpus Luteum: A Possible Contribution to Reproductive Process 55
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 53
Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk 51
Insulin-sensitizing effect and antioxidant action of alpha lipoic acid in oligomenorrheic women with polycystic ovary syndrome 33
Totale 1.898
Categoria #
all - tutte 8.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020107 0 0 0 0 0 0 30 4 10 8 36 19
2020/2021143 6 15 6 16 12 10 19 1 17 5 27 9
2021/2022213 12 12 3 10 13 6 4 43 7 10 45 48
2022/2023589 69 86 38 99 25 78 25 40 84 9 28 8
2023/2024293 5 83 7 9 16 77 37 7 6 10 16 20
2024/2025169 13 15 51 12 66 12 0 0 0 0 0 0
Totale 1.898